Abstract
After cancer, viral infections constitute a great threat to human health throughout the world and among these viral hepatitis constitutes one of the most important public threats in the world. Despite considerable advances in medical technology and attempts to eradicate the diseases, viral hepatitis still remain as major public health problem with their high morbidity and mortality in the Mediterranean, Eastern Europe, Middle East and elsewhere. Uncontrolled migratory flow from developing countries to regions of low endemicity gave rise to changes not only in the prevalence of viral infection but also the genotype, clinical course and modes of transmission. Among several viruses which may affect the liver those which constitute important public health problems are hepatitis A, B, C, D, and E. All of these viruses can cause an acute disease with symptoms lasting several weeks however HBV can cause asymptomatic infection which can silently progress to chronic infection in which the patient never gets rid of the virus and many years later develops cirrhosis of the liver or liver cancer. Of the two billion people who have been infected with HBV, more than 350 million have chronic (lifelong) infections. In this chapter, we reviewed the present situation, epidemiology, clinical presentation, prevention, diagnostic techniques and the universal importance of Hepatitis B.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- ALT:
-
Alanine aminotransferase
- anti-HBc:
-
Antibody to hepatitis B virus core antigen
- anti-Hbe:
-
Antibody to hepatitis B virus e antigen
- bps:
-
Bits per second
- DNA:
-
Deoxyribonucleic acid
- EU:
-
European Union
- HCW:
-
Health care workers
- HBV:
-
Hepatitis B virus
- HCC:
-
Hepatocellular carcinoma
- anti-HBs:
-
Hepatitis B surface antibody
- HbeAg:
-
Hepatitis B virus e antigen
- HbsAg:
-
Hepatitis B virus surface antigen
- HIV:
-
Human immune deficiency virus
- RNA:
-
Ribonucleic acid
- USSR:
-
Union of Soviet Socialist Republics
- WHO:
-
World Health Organization
References
Alter MJ (2003) Epidemiology of hepatitis B in Europe and worldwide. J Hepatol 39:64–69
Alter MJ, Margolis HS (1990) The emergence of hepatitis B as a sexually transmitted disease. Med Clin N Am 74:1529–1541
Alter HJ, Seeff LB, Kaplan PM, McAuliffe VJ, Wright EC, Gerin JL et al (1976) Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure. N Engl J Med 295:909–913
Alter HJ, Purcell RH, Gerin JL, London WT, Kaplan PM, McAuliffe VJ et al (1977) Transmission of hepatitis B to chimpanzees by hepatitis B surface antigen-positive saliva and semen. Infect Immun 16:928–933
Alter MJ, Ahtone J, Maynard JE (1983) Multiple-dose vial associated with transmission of hepatitis B virus in a hemodialysis unit. Ann Intern Med 99:330–333
Amato-Gauci A, Ammon A (2007) ECDC to launch first report on communicable diseases epidemiology in the European Union. Euro Surveill. 12(6):E070607.2
Attila L (2006) Nucleic acid testing for human disease by Taylor & Francis group, chapter 2, pp 19–65
Bancroft WH, Snitbhan R, Scott RM, Tingpalapong M, Watson WT, Tanticharoenyos P, et al (1977) Transmission of hepatitis B virus to gibbons by exposure to human saliva containing hepatitis B surface antigen. J Infect Dis 135:79–85
Barlet V, Cohard M, Thelu MA, Chaix MJ, Baccard C, Zarski JP, Seigneurin JM (Sep 1994) Quantitative detection of hepatitis B virus DNA in serum using chemiluminescence: comparison with radioactive solution hybridization assay. J Virol Methods 49(2):141–151
Benner SA, Steven A, Sismour M (July 2005) Synthetic biology. Nat Rev Gen 6:533–543
Bernard PS, Wittwer CT (Aug 2002) Real-time PCR technology for cancer diagnostics. Clin Chem 48(8):1178–1185 (Review)
Brechtbuehl K, Whalley SA, Dusheiko GM, Saunders NA (Apr 2001) A rapid real-time quantitative polymerase chain reaction for hepatitis B virus. J Virol Methods 93(1–2):105–113
Brunetto MR, Moriconi F, Bonino F, Lau GK, Farci P, Yurdaydin C, Piratvisuth T, Luo K, Wang Y, Hadziyannis S, Wolf E, McCloud P, Batrla R, Marcellin P (Apr 2009) Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B. Hepatology 49(4):1141–1150
Chan HL, Hui AY, Wong ML, Tse AM, Hung LC, Wong VW, Sung JJ (2004) Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma. Gut 53:1494–1498
Chan HL, Wong VW, Tse AM, Tse CH, Chim AM, Chan HY, Wong GL, Sung JJ (Dec 2007) Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response. Clin Gastroenterol Hepatol 5(12):1462–1468
Chang MH (2009) Cancer prevention by vaccination against hepatitis B. Recent Results Cancer Res 181:85–94 (Review)
Chevaliez S, Pawlotsky JM (7 May 2007) Hepatitis C virus: virology, diagnosis and management of antiviral therapy. World J Gastroenterol 13(17):2461–2466 (Review)
Chevaliez S, Pawlotsky JM (Jan–Mar 2009) Virological techniques for the diagnosis and monitoring of hepatitis B and C. Ann Hepatol 8(1):7–12 (Review)
Chu CJ, Keeffe EB, Han SH, Perrillo RP, Min AD, Soldevila-Pico C, Carey W, Brown RS Jr, Luketic VA, Terrault N, Lok AS (2003) Hepatitis B virus genotypes in the United States: results of a nationwide survey. Gastroenterology 125:444
Da Villa G, Piccinino F, Scolastico C, Fusco M, Piccinino R, Sepe A (1998) Long-term epidemiological survey of hepatitis B virus infection in a hyperendemic area (Afragola, Southern Italy): results of a pilot vaccination project. Res Virol 149:263–270
Dal-Re R, Aguilar L, Coronel P (1991) Current prevalence of hepatitis B, A and C in a healthy Spanish population. A seroepidemiological study. Infection 19:409–413
Degertekin H, Tuzcu A, Yalcin K (2000) Horizontal transmission of HBV infection among students in Turkey. Public Health 114:411–412
EASL (2009) EASL clinical practice guidelines: management of chronic hepatitis B. J Hepatol 50:227–242
Esteban JI, Sauleda S, Quer J (2008) The changing epidemiology of hepatitis C infection in Europe. J Hepatol 48:148–162
Fattovich G (2003) Natural history and prognosis of hepatitis B. Semin Liver Dis 23:47–68
Fattovich G, Pantalena M, Zagni I, Realdi G, Schalm SW, Christensen E (2002) Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients. Am J Gastroenterol 97:2886–2895
Fattovich G, Bortolotti F, Donato F (2008) Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol 48:335–352
Fung SK, Lok ASF (2004) Treatment of chronic hepatitis B: who to treat, what to use, and for how long? Clin Gastroenterol Hepatol 2:839–848
Gauthier J, Bourne EJ, Lutz MW, Crowther LM, Dienstag JL, Brown NA, Condreay LD (Dec 1999) Quantitation of hepatitis B viremia and emergence of YMDD variants in patients with chronic hepatitis B treated with lamivudine. J Infect Dis 180(6):1757–1762
Gibb R, Nimmo GR, O’Loughlin P, Lowe P, Drummond D (2007) Detection of HBsAg mutants in a population with a low prevalence of hepatitis B virus infection. J Med Virol 79:351–355
Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV (1999) Viral clearance without destruction of infected cells during acute HBV infection. Science 284:825–829
Hendricks DA, Stowe BJ, Hoo BS, Kolberg J, Irvine BD, Neuwald PD, Urdea MS (Nov 1995) Perrillo RP Quantitation of HBV DNA in human serum using a branched DNA (bDNA) signal amplification assay. Am J Clin Pathol 104(5):537–546
Ho SK, Chan TM, Cheng IK, Lai KN (Aug 1999) Comparison of the second-generation digene hybrid capture assay with the branched-DNA assay for measurement of hepatitis B virus DNA in serum. J Clin Microbiol 37(8):2461–2465
Hsieh CC, Tzonou A, Zavitsanos X, Kaklamani E, Lan SJ, Trichopoulos D (1992) Age at first establishment of chronic hepatitis B virus infection and hepatocellular carcinoma risk. A birth order study. Am J Epidemiol 136:1115–1121
Hui AY, Chan HL, Leung NW, Hung LC, Chan FK, Sung JJ (2002) Survival and prognostic indicators in patients with hepatitis B virus-related cirrhosis after onset of hepatic decompensation. J Clin Gastroenterol 34:569–572
Hui CK, Leung N, Yuen ST, Zhang HY, Leung KW, Lu L et al (2007) Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase. Hepatology 46:395–401
Hutin YJ, Harpaz R, Drobeniuc J, Melnic A, Ray C, Favorov M et al (1999) Injections given in healthcare settings as a major source of acute hepatitis B in Moldova. Int J Epidemiol 28:782–786
Kane A, Lloyd J, Zaffran M et al (1999) Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model- based regional estimates. Bull World Health Organ 77(10):801–807
Kao JH (2007) Role of viral factors in the natural course and therapy of chronic hepatitis B. Hepatol Int 1:415–430
Kao JH, Chen PJ, Lai MY, Chen DS (2000) Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology 118:554–559
Kent GB, Brondum J, Keenlyside RA, LaFazia LM, Scott HD (1988) A large outbreak of acupuncture- associated hepatitis B. Am J Epidemiol 127:591–598
Kyriakis KP, Foudoulaki LE, Papoulia EI, Sofroniadou KE (2000) Seroprevalence of hepatitis B surface antigen (HBsAg) among first-time and sporadic blood donors in Greece: 1991–1996. Transfusion Med 10:175–180
Lavanchy D (2004) Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepatol 11:97–107
Lee WM (1997) Hepatitis B virus infection. N Engl J Med 337(24):1733–1745
Liaw JF, Chu CM (2009) Hepatitis B virus infection. Lancet 373:582–592
Limentani AE, Elliott LM (1979) An outbreak of hepatitis B from tattooing. Lancet 2:86–88
Lin HH, Kao JH, Chang TC, Hsu HY, Chen DS (2003) Secular trend of age-specific prevalence of hepatitis B surface and e antigenemia in pregnant women in Taiwan. J Med Virol 69:466–470
Lionis C, Koulentaki M, Biziagos E, Kouroumalis E (1997) Current prevalence of hepatitis A, B and C in a well-defined area in rural Crete, Greece. J Viral Hepatitis 4:55–61
Loeb KR, Jerome KR, Goddard J, Huang M, Cent A, Corey L (Sep 2000) High-throughput quantitative analysis of hepatitis B virus DNA in serum using the TaqMan fluorogenic detection system. Hepatology 32(3):626–629
Lok AS (2002) Chronic hepatitis B. N Engl J Med 346(22):1682–1683
Lok AS, McMahon BJ (2007) Chronic hepatitis B. Hepatology 45:507–539
Lok AS, Heathcote EJ, Hoofnagle JH (2001) Management of hepatitis B: 2000 – summary of a workshop. Gastroenterology 120(7):1828–1853
Lopez VA, Bourne EJ, Lutz MW, Condreay LD (Jun 2002) Assessment of the COBAS Amplicor HBV Monitor Test for quantitation of serum hepatitis B virus DNA levels. J Clin Microbiol 40(6):1972–1976
Lorinez A (2006) Nucleic acid testing for human disease in nucleic acid techonology. CRC Press/Taylor & Francis, Boca Raton, FL co. 616.075 LOR. (ISSN 1-57444-543-X)
Mackay IM (2004) Real-Time PCR in the microbiology laboratory. Clin Microbiol Infect 10:190–212
Magdzik W (2000) Hepatitis B epidemiology in Poland, Central and Eastern Europe and the newly independent states. Vaccine 18:S13–S16
Mahoney FJ (1999) Update on diagnosis, management, and prevention of hepatitis B virus infection. Clin Microbiol Rev 12(2):351–366
Maini MK, Boni C, Lee CK et al (2000) The role of virus-specifi c CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med 191:1269–1280
Manesis EK (2006) HBeAg-negative chronic hepatitis B: from obscurity to prominence. J Hepatol 45:343–346
Marin IJ, Poljak M, Seme K, Meglic-Volkar J, Maticic M, Lesnicar G, Brinovec V (Feb 2001) Comparative evaluation of semiautomated COBAS AMPLICOR hepatitis B virus (HBV) monitor test and manual microwell plate-based AMPLICOR HBV MONITOR test. J Clin Microbiol 39(2):758–761
Marion SA, Pastore MT, Pi DW, Mathias RG (1994) Longterm follow-up of hepatitis B vaccine in infants of carrier mothers. Am J Epidemiol 140:734–746
Martinot-Peignoux M, Boyer N, Colombat M, Akremi R, Pham BN, Ollivier S et al (2002) Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers. J Hepatol 36:543–546
Mazokopakis E, Vlachonikolis J, Philalithis A, Lionis C (2000) Seroprevalence of hepatitis A, B and C markers in Greek warship personnel. Eur J Epidemiol 16:1069–1072
McKnight CA, Des Jarlais DC, Perlis T, Eigo K (2007) Syringe exchange programs—United States, 2005. MMWR Morb Mortal Wkly Rep 56:1164–67
Mele A, Tancredi F, Romano L, Giuseppone A, Colucci M, Sangiuolo A, Lecce R, Adamo B, Tosti ME, Taliani G, Zanetti AR (2001) Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy. J Infect Dis 184:905–908
Muhlbacher A, Weber B, Burgisser P, Eiras A, Cabrera J, Louisirirotchanakul S, Tiller FW et al (2008) Multicenter study of a new fully automated HBsAg screening assay with enhanced sensitivity for the detection of HBV mutants. Med Microbiol Immunol 197:55–64
Murray JM, Wieland SF, Purcell RH, Chisari FV (2005) Dynamics of hepatitis B virus clearance in chimpanzees. Proc Natl Acad Sci USA 102:17780–17785
Ni Y-H, Chang M-H, Huang L-M, Chen HL, Hsu HY, Chiu TY et al (2001) Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med 135:796–800
Ni YH, Chang MH, Wang KJ et al (2004) Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma. Gastroenterology 127:1733–1738
Ozaras R, Tabak F, Tahan V, Ozturk R, Akin H, Mert A, Senturk H (2008) Correlation of quantitative assay of HBsAg and HBV DNA levels during chronic HBV treatment. Dig Dis Sci 53:2995–2998
Palumbo E, Scotto G, Cibelli D, Faleo G, Saracin A, Angarano G (2008) Immigration and hepatitis B virus: epidemiological, clinical and therapeutic aspects. La Revue de Santé de la Méditerranée orientale 14(4):784–790
Parkin DM, Bray F, Ferlay J, Pisani P (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer 94(2):153–156
Pawlotsky JM.Molecular diagnosis of viral hepatitis. Gastroenterology 2002;122:1554-1568
Perz JF, Elm JL Jr, Fiore AE, Huggler JI, Kuhnert WL, Effler PV (2006a) Near elimination of hepatitis B virus infections among Hawaii elementary school children after universal hepatitis B vaccination. Pediatrics 118:1403
Perz JF, Armstrong GL, Farrington LA et al (2006b) The contribution of hepatitis B and hepatitis C virus infection to cirrhosis and primary liver cancer worldwide. J Hepatol 45:529–538
Ronsin C, Pillet A, Bali C, Denoyel GA (Apr 2006) Evaluation of the COBAS Ampli Prep-total nucleic acid isolation-COBAS TaqMan hepatitis B virus (HBV) quantitative test and comparison to the VERSANT HBV DNA 3.0 assay. J Clin Microbiol 44(4):1390–1399
Sakugawa H, Kobashigawa K, Nakayoshi T, Yamashiro T, Maeshiro T, Tomimori K, Kinjo F, Saito A, Mukaide M (Aug 2003) Monitoring low level hepatitis B virus by a newly developed sensitive test. Hepatol Res 26(4):281–286
Schmunis GA, Zicker F, Cruz JR, Cuchi P (2001) Safety of blood supply for infectious diseases in Latin American countries, 1994–1997. Am J Trop Med Hyg 65(6):924–930
Simonsen L, Kane A, Lloyd J, Zaffran M, Kane M (1999) Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. Bull World Health Organ 77(10):789–800
Stelzl E, Muller Z, Marth E, Kessler HH (Jun 2004) Rapid quantification of hepatitis B virus DNA by automated sample preparation and real-time PCR. J Clin Microbiol 42(6):2445–2449
Summers J, Mason WS (1982) Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 29:403–415
Toy M, Önder FM, Wormann T, Richardus JH, Schalm S, İdilman H, Değertekin H, Yurdaydın C (2009) Pevalance of hepatitis B in turkey: meta-analysis -abstract. 7th National Meeting of Hepatology, Izmir,Turkey, 10–14 June 2009 (abstract book)
Ture Ozdemir F, Duman D, Ertem D, Avsar E, Ozdogan O, Eren F, Kalaycı C, Aslan N, Bozdayı AM, Tozun N (Dec 2005) Determination of hepatitis B genotypes in patients with chronic hepatitis B virus infection in Turkey. Turk J Gastroenterol 16(4):183–187
Weber B, Van der Taelem-Brule N, Berger A, Simon F, Geudin M, Ritter J (2006) Evaluation of a new automated assay for hepatitis B surface antigen (HBsAg) detection Vidas HBsAg ultra. J Virol Methods 135:109–117
Wheeley SM, Boxall EH, Tarlow MJ, Gatrad AR, Anderson J, Bissenden J, Chin KC, Mayne A (1990) Hepatitis B vaccine in the prevention of perinatally transmitted hepatitis B virus infection: final report on a west midlands pilot study. J MedVirol 30:113–116
Wong ML, Medrano JF (July 2005) Real-time PCR for mRNA quantitation. Biotechniques 39(1):75–85 (Review)
Wong VCW, Ip HMH, Reesink HW, Kuhns MC (1984) Prevention of the HBsAg-carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis vaccine and hepatitis-B immunoglobulin. Lancet 8383:921–926
World Health Organization (2000) Hepatitis B. World Health Organization Fact Sheet 204 (Revised October 2000). WHO Web site. 2000. http://who.int/inf-fs/en/fact204.html
Worman HJ (Aug 1997) Molecular biological methods in diagnosis and treatment of liver diseases. Clin Chem 43(8 Pt 2):1476–1486
Xu ZY, Duan SC, Margolis HS (1995) Long-term efficacy of active postexposure immunization of infants for prevention of hepatitis B virus infection. United States-people’s republic of China study group on hepatitis B. J Infect Dis 171:54–60
Yao JD, Beld MG, Oon LL, Sherlock CH, Germer J, Menting S, Se Thoe SY, Merrick L, Ziermann R, Surtihadi J, Hnatyszyn HJ (Feb 2004) Multicenter evaluation of the VERSANT hepatitis B virus DNA 3.0 assay. J Clin Microbiol 42(2):800–806
Yuen MF, Sablon E, Tanaka Y, Kato T, Mizokami M, Doutreloigne J, Yuan HJ, Wong DK, Sum SM, Lai CL (2004) Epidemiological study of hepatitis B virus genotypes, core promoter and precore mutations of chronic hepatitis B infection in Hong Kong. J Hepatol 41:119–125
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media B.V.
About this paper
Cite this paper
Tözün, N., Ersoy, Ö., Eren, F., Tahan, V. (2010). Epidemiology and Diagnosis of Hepatitis B in the Mediterranean Region and Elsewhere. In: Viola Magni, M. (eds) Detection of Bacteria, Viruses, Parasites and Fungi. NATO Science for Peace and Security Series A: Chemistry and Biology. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-8544-3_10
Download citation
DOI: https://doi.org/10.1007/978-90-481-8544-3_10
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-8542-9
Online ISBN: 978-90-481-8544-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)